Assertio Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
November 26 2019 - 2:29PM
Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that
members of senior management will participate at the 31st Annual
Piper Jaffray Healthcare Conference in a session scheduled for 9:30
a.m. ET, Thursday, December 5, 2019 in New York, NY.
This presentation will be webcast and can be accessed via the
Investor Relations page of the Assertio website at
http://investor.assertiotx.com. Please access the website 15
minutes prior to the start of the call to download and install any
necessary audio software. A recording of the webcast will be
archived.
About Assertio Therapeutics, Inc.Assertio
Therapeutics is committed to providing responsible solutions to
advance patient care in the Company’s core areas of neurology,
orphan and specialty medicines. Assertio currently markets three
FDA-approved products and continues to identify, license and
develop new products that offer enhanced options for patients that
may be underserved by existing therapies. To learn more about
Assertio, visit www.assertiotx.com.
"Safe Harbor" Statement under the Private Securities
Litigation Reform Act of 1995 This news release contains
forward-looking statements. These statements involve inherent risks
and uncertainties that could cause actual results to differ
materially from those projected or anticipated, including risks
related to regulatory approval and clinical development of
long-acting cosyntropin, expectations regarding potential business
opportunities and other risks outlined in the Company's public
filings with the Securities and Exchange Commission, including the
Company's most recent annual report on Form 10-K and subsequent
Quarterly Reports on Form 10-Q. All information provided in this
news release speaks as of the date hereof. Except as otherwise
required by law, the Company undertakes no obligation to update or
revise its forward-looking statements.
Investor and Media Contact:John B. ThomasSVP,
Investor Relations and Corporate
Communicationsjthomas@assertiotx.com
Source: Assertio Therapeutics, Inc.
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Sep 2023 to Sep 2024